The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Engineering Editing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Homologous Recombination
1.2.3 Meganuclease
1.3 Market by Application
1.3.1 Global Genome Engineering Editing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Agriculture
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Engineering Editing Market Perspective (2018-2029)
2.2 Genome Engineering Editing Growth Trends by Region
2.2.1 Global Genome Engineering Editing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genome Engineering Editing Historic Market Size by Region (2018-2023)
2.2.3 Genome Engineering Editing Forecasted Market Size by Region (2024-2029)
2.3 Genome Engineering Editing Market Dynamics
2.3.1 Genome Engineering Editing Industry Trends
2.3.2 Genome Engineering Editing Market Drivers
2.3.3 Genome Engineering Editing Market Challenges
2.3.4 Genome Engineering Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Engineering Editing Players by Revenue
3.1.1 Global Top Genome Engineering Editing Players by Revenue (2018-2023)
3.1.2 Global Genome Engineering Editing Revenue Market Share by Players (2018-2023)
3.2 Global Genome Engineering Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Engineering Editing Revenue
3.4 Global Genome Engineering Editing Market Concentration Ratio
3.4.1 Global Genome Engineering Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Engineering Editing Revenue in 2022
3.5 Genome Engineering Editing Key Players Head office and Area Served
3.6 Key Players Genome Engineering Editing Product Solution and Service
3.7 Date of Enter into Genome Engineering Editing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Engineering Editing Breakdown Data by Type
4.1 Global Genome Engineering Editing Historic Market Size by Type (2018-2023)
4.2 Global Genome Engineering Editing Forecasted Market Size by Type (2024-2029)
5 Genome Engineering Editing Breakdown Data by Application
5.1 Global Genome Engineering Editing Historic Market Size by Application (2018-2023)
5.2 Global Genome Engineering Editing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genome Engineering Editing Market Size (2018-2029)
6.2 North America Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genome Engineering Editing Market Size by Country (2018-2023)
6.4 North America Genome Engineering Editing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Engineering Editing Market Size (2018-2029)
7.2 Europe Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genome Engineering Editing Market Size by Country (2018-2023)
7.4 Europe Genome Engineering Editing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Engineering Editing Market Size (2018-2029)
8.2 Asia-Pacific Genome Engineering Editing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genome Engineering Editing Market Size by Region (2018-2023)
8.4 Asia-Pacific Genome Engineering Editing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Engineering Editing Market Size (2018-2029)
9.2 Latin America Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genome Engineering Editing Market Size by Country (2018-2023)
9.4 Latin America Genome Engineering Editing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Engineering Editing Market Size (2018-2029)
10.2 Middle East & Africa Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genome Engineering Editing Market Size by Country (2018-2023)
10.4 Middle East & Africa Genome Engineering Editing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genome Engineering Editing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genome Engineering Editing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 SIGMA ALDRICH
11.2.1 SIGMA ALDRICH Company Detail
11.2.2 SIGMA ALDRICH Business Overview
11.2.3 SIGMA ALDRICH Genome Engineering Editing Introduction
11.2.4 SIGMA ALDRICH Revenue in Genome Engineering Editing Business (2018-2023)
11.2.5 SIGMA ALDRICH Recent Development
11.3 Dharmacon
11.3.1 Dharmacon Company Detail
11.3.2 Dharmacon Business Overview
11.3.3 Dharmacon Genome Engineering Editing Introduction
11.3.4 Dharmacon Revenue in Genome Engineering Editing Business (2018-2023)
11.3.5 Dharmacon Recent Development
11.4 Cellectics
11.4.1 Cellectics Company Detail
11.4.2 Cellectics Business Overview
11.4.3 Cellectics Genome Engineering Editing Introduction
11.4.4 Cellectics Revenue in Genome Engineering Editing Business (2018-2023)
11.4.5 Cellectics Recent Development
11.5 CRISPR Therapeutics
11.5.1 CRISPR Therapeutics Company Detail
11.5.2 CRISPR Therapeutics Business Overview
11.5.3 CRISPR Therapeutics Genome Engineering Editing Introduction
11.5.4 CRISPR Therapeutics Revenue in Genome Engineering Editing Business (2018-2023)
11.5.5 CRISPR Therapeutics Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Genome Engineering Editing Introduction
11.6.4 AstraZeneca Revenue in Genome Engineering Editing Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Bio Rad
11.7.1 Bio Rad Company Detail
11.7.2 Bio Rad Business Overview
11.7.3 Bio Rad Genome Engineering Editing Introduction
11.7.4 Bio Rad Revenue in Genome Engineering Editing Business (2018-2023)
11.7.5 Bio Rad Recent Development
11.8 Allele Biotech
11.8.1 Allele Biotech Company Detail
11.8.2 Allele Biotech Business Overview
11.8.3 Allele Biotech Genome Engineering Editing Introduction
11.8.4 Allele Biotech Revenue in Genome Engineering Editing Business (2018-2023)
11.8.5 Allele Biotech Recent Development
11.9 Recombinetics
11.9.1 Recombinetics Company Detail
11.9.2 Recombinetics Business Overview
11.9.3 Recombinetics Genome Engineering Editing Introduction
11.9.4 Recombinetics Revenue in Genome Engineering Editing Business (2018-2023)
11.9.5 Recombinetics Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Genome Engineering Editing Introduction
11.10.4 Lonza Revenue in Genome Engineering Editing Business (2018-2023)
11.10.5 Lonza Recent Development
11.11 GE Healthcare
11.11.1 GE Healthcare Company Detail
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Genome Engineering Editing Introduction
11.11.4 GE Healthcare Revenue in Genome Engineering Editing Business (2018-2023)
11.11.5 GE Healthcare Recent Development
11.12 Editas Medicine
11.12.1 Editas Medicine Company Detail
11.12.2 Editas Medicine Business Overview
11.12.3 Editas Medicine Genome Engineering Editing Introduction
11.12.4 Editas Medicine Revenue in Genome Engineering Editing Business (2018-2023)
11.12.5 Editas Medicine Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Detail
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Genome Engineering Editing Introduction
11.13.4 Agilent Technologies Revenue in Genome Engineering Editing Business (2018-2023)
11.13.5 Agilent Technologies Recent Development
11.14 QIAGEN NV
11.14.1 QIAGEN NV Company Detail
11.14.2 QIAGEN NV Business Overview
11.14.3 QIAGEN NV Genome Engineering Editing Introduction
11.14.4 QIAGEN NV Revenue in Genome Engineering Editing Business (2018-2023)
11.14.5 QIAGEN NV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details